Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/AKT/mTOR signaling pathway

Chemosensitizing Effect of Astragalus Polysaccharides on Nasopharyngeal Carcinoma Cells by Inducing Apoptosis and Modulating Expression of Bax/Bcl-2 Ratio and Caspases

(2017) Zhen Zhou et al.   MEDICAL SCIENCE MONITOR

Astragalus membranaceus: A Review of its Protection Against Inflammation and Gastrointestinal Cancers

(2016) Kathy K. Auyeung et al.   AMERICAN JOURNAL OF CHINESE MEDICINE

Incidence and Mortality and Epidemiology of Breast Cancer in the World

(2016) Mahshid Ghoncheh et al.   Asian Pacific Journal of Cancer Prevention

PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment

(2016) Angel Guerrero-Zotano et al.   CANCER AND METASTASIS REVIEWS

Astragaloside IV Enhances Cisplatin Chemosensitivity in Non-Small Cell Lung Cancer Cells Through Inhibition of B7-H3

(2016) Cheng-Shi He et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Astragalus-containing Traditional Chinese Medicine, with and without prescription based on syndrome differentiation, combined with chemotherapy for advanced non-small-cell lung cancer: a systemic review and meta-analysis

(2016) S.F. Wang et al.   Current Oncology

Astragalus polysaccharide induces the apoptosis of human hepatocellular carcinoma cells by decreasing the expression of Notch1

(2016) Wen-Hai Huang et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Bortezomib Inhibits Giant Cell Tumor of Bone through Induction of Cell Apoptosis and Inhibition of Osteoclast Recruitment, Giant Cell Formation, and Bone Resorption

(2016) L. Xu et al.   MOLECULAR CANCER THERAPEUTICS

Suppression of A549 cell proliferation and metastasis by calycosin via inhibition of the PKC-α/ERK1/2 pathway: An in vitro investigation

(2015) XU-DONG CHENG et al.   Molecular Medicine Reports

Effects and mechanism of flavonoids from Astragalus complanatus on breast cancer growth

(2015) Jinhai Zhu et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

An in vivo molecular response analysis of colorectal cancer treated with Astragalus membranaceus extract

(2015) AILUN TSENG et al.   ONCOLOGY REPORTS

Astragalus saponins modulates colon cancer development by regulating calpain-mediated glucose-regulated protein expression

(2014) Yue Wang et al.   BMC Complementary and Alternative Medicine

Formononetin Inhibits Migration and Invasion of MDA-MB-231 and 4T1 Breast Cancer Cells by Suppressing MMP-2 and MMP-9 Through PI3K/AKT Signaling Pathways

(2014) R. Zhou et al.   HORMONE AND METABOLIC RESEARCH

Review of the Botanical Characteristics, Phytochemistry, and Pharmacology ofAstragalus membranaceus(Huangqi)

(2014) Juan Fu et al.   PHYTOTHERAPY RESEARCH

Targeting PI3K/Akt/mTOR Signaling in Cancer

(2014) Camillo Porta et al.   Frontiers in Oncology

In vitro and in vivo anti-cancer activity of formononetin on human cervical cancer cell line HeLa

(2013) Yue-mei Jin et al.   TUMOR BIOLOGY

Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancer

(2012) A.M. Gonzalez-Angulo et al.   CANCER TREATMENT REVIEWS

Anti-tumor effects of Astragalus on hepatocellular carcinoma in vivo

(2012) Li-Hong Wan et al.   INDIAN JOURNAL OF PHARMACOLOGY

Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy

(2012) Justin Cidado et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Influence of extraction methods on stability of flavonoids

(2011) Magdalena Biesaga   JOURNAL OF CHROMATOGRAPHY A

Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients

(2009) Sandra Ghayad et al.   Recent Patents on Anti-Cancer Drug Discovery